Success Metrics

Clinical Success Rate
91.1%

Based on 194 completed trials

Completion Rate
91%(194/213)
Active Trials
14(5%)
Results Posted
49%(96 trials)
Terminated
19(7%)

Phase Distribution

Ph phase_4
40
15%
Ph phase_3
72
26%
Ph phase_2
68
25%
Ph early_phase_1
8
3%
Ph phase_1
19
7%
Ph not_applicable
36
13%

Phase Distribution

27

Early Stage

68

Mid Stage

112

Late Stage

Phase Distribution243 total trials
Early Phase 1First-in-human
8(3.3%)
Phase 1Safety & dosage
19(7.8%)
Phase 2Efficacy & side effects
68(28.0%)
Phase 3Large-scale testing
72(29.6%)
Phase 4Post-market surveillance
40(16.5%)
N/ANon-phased studies
36(14.8%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

87.8%

194 of 221 finished

Non-Completion Rate

12.2%

27 ended early

Currently Active

14

trials recruiting

Total Trials

274

all time

Status Distribution
Active(19)
Completed(194)
Terminated(27)
Other(34)

Detailed Status

Completed194
unknown34
Terminated19
Recruiting9
Withdrawn8
Active, not recruiting5

Development Timeline

Analytics

Development Status

Total Trials
274
Active
14
Success Rate
91.1%
Most Advanced
Phase 4

Trials by Phase

Early Phase 18 (3.3%)
Phase 119 (7.8%)
Phase 268 (28.0%)
Phase 372 (29.6%)
Phase 440 (16.5%)
N/A36 (14.8%)

Trials by Status

enrolling_by_invitation21%
withdrawn83%
not_yet_recruiting31%
active_not_recruiting52%
unknown3412%
completed19471%
recruiting93%
terminated197%

Recent Activity

Clinical Trials (274)

Showing 20 of 274 trialsScroll for more
NCT06385171

Assessing the Impact of Botulinum Toxin Type A on Facial Wrinkles: A Comprehensive Clinical Investigation

Withdrawn
NCT04069897Phase 3

Botulinum Toxin Type A Blockade of the Sphenopalatine Ganglion in Treatment-refractory Chronic Migraine

Completed
NCT07758322Not Applicable

Efficacy of Focused Shock Wave Therapy Before and After Botulinum Toxin Injection in Patients With Post-Stroke Spastic Equinus/Equinovarus Foot: A Randomized Clinical Trial

Active Not Recruiting
NCT05720065Phase 2

Peripheral TMD Pain Mechanisms and the Effect by Botulinum Toxin A

Recruiting
NCT03654066Phase 4

Botox or Botox With Esophageal Dilation in Patients With Achalasia

Enrolling By Invitation
NCT05892770Phase 1

Zinc Supplementation Prior to Botox Injections for Spasmodic Dysphonia

Completed
NCT06047444Phase 3

A Study to Evaluate the Effectiveness and Safety of Dysport® for the Prevention of Chronic Migraine in Adults

Active Not Recruiting
NCT06047457Phase 3

A Study to Evaluate the Effectiveness and Safety of Dysport® for the Prevention of Episodic Migraine in Adults

Active Not Recruiting
NCT06448676Phase 4

Head-to-Head Comparison of All Botulinum Neurotoxin Type A Products for Glabellar Rhytides

Recruiting
NCT07666347Not Applicable

Intraarticular Injection of Botox and Hyaluronic Acid in Knee Osteoarthritis

Recruiting
NCT06296082Phase 2

Comparative Study of the Effects of Dry Needling and Botulinum Toxin Type A as a Treatment for Lower Limb Post-stroke Spasticity

Recruiting
NCT07561580Not Applicable

Botulinum Toxin Type A for Frontal Hyperhidrosis

Recruiting
NCT07399860Phase 2

Botulinum Toxin A Before Hemorrhoidectomy to Prevent Postoperative Pain

Recruiting
NCT06237465Phase 4

Botulinum Toxin-A for Hidradenitis Suppurativa

Withdrawn
NCT06356025Phase 4

Botulinum Toxin Injection in the UES for R-CPD

Active Not Recruiting
NCT07236632Not Applicable

Hyaluronic Acid vs Botulinum Toxin Injection in Treatment of Lifelong Drug-Resistant Premature Ejaculation: Randomized Study

Not Yet Recruiting
NCT05330078Early Phase 1

Examining the Therapeutic Potential of Botulinum Toxin Type A in the Treatment of Keloids

Completed
NCT06349733Early Phase 1

A Dosage-dependent Manner of Botulinum Toxin Type A on the Prevention of Postoperative Scars of Various Anatomic Regions of the Body

Completed
NCT06974617Not Applicable

Sphenopalatine Block Versus BOTOX in Management of Chronic Migraine

Recruiting
NCT04965311Phase 2

Endoscopic Botulinum Toxin Injection in the Prevention of Postoperative Pancreatic Fistula Following Distal Pancreatectomy

Terminated

Drug Details

Intervention Type
DRUG
Total Trials
274